Ad
CryptoSlate on X
Follow us on X for instant crypto news and insights updates.
Join 50k followers
 Ad

CryptoSlate does not endorse or rate any crypto projects. Please read our coin database disclaimer for more information. Read More | Hide This

Market Cap
$11.05M
Sectors Blockchain

GENEXI Info

Genexi accelerates the transition of cutting-edge biotech projects from research to the market. GEN token is qualified as a utility token. The token will be used as a medium of exchange within the ecosystem.

GENEXI Video

GENEXI Technical Info

  • Blockchain
  • Hash Algorithm None
  • Org. Structure Centralized
  • Development Status Alpha version
  • Open Source Yes
  • Hard Wallet Support Yes

GENEXI Organization & Team

GENEXI
Alexey Zhelyaskov

Co-Founder, CEO

GENEXI
Aleksei Kirillov

Co-Founder, COO

GENEXI
Roman Gilvanov

Managing Director

GENEXI
Sergey Tiurin

Head of Medical Research

GENEXI
Andrew Zharkov

Head of Finance

GENEXI
Alexey Nosikov

Head of Operations

GENEXI
Andrew Marcus

Head of Strategy

GENEXI
Bogdan Stepanov

Head of Business Development

GENEXI
Anton Sklovets

Head of Research

GENEXI
Daria Goriychuk

Head of HR

GENEXI Intel

Powered by

GENEXI ICO Details

GENEXI launched its token sale on Jun 1, 2018 and completed it on Jul 31, 2018. It raised a total of .

The total supply available for purchase during the token sale was 12,000,000,000 GEN.

GENEXI ICO Stats

  • ICO Start Date Jun 1, 2018
  • ICO End Date Jul 31, 2018
  • Soft Cap 20,000,000 USD
  • Hard Cap 70,000,000 USD
  • Total Supply 12,000,000,000 GEN
  • Investor Supply 8.400,000,000 GEN
  • ICO Conversion

    1 GEN = 0.01 USD

Suggest an Edit · Report Project

All images, branding and wording is copyright of GENEXI. All content on this page is used for informational purposes only. CryptoSlate has no affiliation or relationship with the coins, projects or people mentioned on this page. Data is provided by CoinMarketCap and TradingView.

 Ad
CryptoSlate on Substack cryptoslate.substack.com
Your daily dose of must-have crypto news and deep dives. Direct to your inbox.
Join 75k subscribers
 Ad